Efficacy and Tolerability of Perospirone in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
@article{Kishi2013EfficacyAT, title={Efficacy and Tolerability of Perospirone in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials}, author={Taro Kishi and Nakao Iwata}, journal={CNS Drugs}, year={2013}, volume={27}, pages={731-741} }
BackgroundPerospirone is a second-generation antipsychotic (SGA) used only in Japan, and acts as a serotonin (5-HT)1A receptor partial agonist, 5-HT2A receptor inverse agonist, and dopamine (D)2, D4, and α1-adrenergic receptor antagonist. To our knowledge, no meta-analysis addressing the efficacy and effectiveness of perospirone in schizophrenia has been published to date.ObjectiveThe aim of the study was to identify the characteristics of perospirone by assessing the efficacy, discontinuation…
12 Citations
Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials
- Psychology, MedicineNeuropsychiatric disease and treatment
- 2015
Although the discontinuation rate associated with inefficacy was higher with aripiprazole than with the pooled antipsychotics, aripIPrazole was associated with a lower risk of hyperprolactinemia and metabolic and extrapyramidal symptoms compared with the pools of antipsychotic drugs.
Cardiometabolic Risks of Blonanserin and Perospirone in the Management of Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Medicine, PsychologyPloS one
- 2014
The results suggest that blonanserin is associated with a lower of weight gain compared with other antipsychotics.
Are Second-Generation Antipsychotics Useful in Tardive Dystonia?
- Medicine, PsychologyClinical neuropharmacology
- 2015
The available evidence points to the effectiveness of clozapine as monotherapy and in combination with clonazepam for the treatment of TDt and olanzapine and quetiapine are reasonable alternatives.
Perospirone Exhibits Antiemetic Efficacy against Opioid-Induced Nausea in Patients with Advanced Cancer.
- MedicineJournal of palliative medicine
- 2015
A retrospective chart review of opioid-naı̈ve patients with advanced cancer who received perospirone as antiemetic against opioid-induced nausea from April 2012 to July 2013 is conducted.
Management of Delirium in Palliative Care: a Review
- Psychology, MedicineCurrent Psychiatry Reports
- 2015
Both conventional and atypical antipsychotics and non-pharmacological interventions were shown to be important in the management of delirium, and more research is necessary to clarify how to more thoroughly manageDelirium in palliative care.
Antipsychotics and the Dopamine–Serotonin Connection
- Psychology, Medicine
- 2014
The aim of the present review is to evaluate the role of dopamine and serotonin receptors in the antipsychotic potential of known as well as potential novel antipsychotics.
Antihyperalgesic effects of intrathecal perospirone in a rat model of neuropathic pain
- Biology, MedicinePharmacology Biochemistry and Behavior
- 2020
Effects of Repetitive Transcranial Magnetic Stimulation Treatment on Event-Related Potentials in Schizophrenia
- Psychology, MedicineChinese medical journal
- 2018
It is believed that the combined usage of N400, mismatch negativity (MMN), and P300 could be a valuable index and an electrophysiological reference in evaluating the effects of rTMS treatment in SZ patients.
Comparing executive functioning and clinical and sociodemographic characteristics of people with schizophrenia who hold a driver’s license to those who do not
- Psychology, MedicineCanadian journal of occupational therapy. Revue canadienne d'ergotherapie
- 2019
This study offers occupational therapists a data-driven perspective on evaluating potential fitness to drive to enable participation in daily life and well-being of people with schizophrenia.
Synthesis and experimental versus theoretical research on spectroscopic and electronic properties of 3-methyl-4-nitroisothiazole
- ChemistryJournal of Molecular Structure
- 2019
References
SHOWING 1-10 OF 21 REFERENCES
Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons.
- Psychology, MedicineSchizophrenia bulletin
- 2012
There are differences between the SGAs in their ability to induce EPS that clinicians consider warrant treatment with antimuscarinic drugs, and they might be important for individual patients and should be taken into account in drug choice.
A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients
- Psychology, MedicineProgress in Neuro-Psychopharmacology and Biological Psychiatry
- 2013
Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study
- Medicine, PsychologyPsychiatry and clinical neurosciences
- 2009
The clinical efficacies and side‐effects of perospirone and risperidone were compared in a randomized clinical multicenter trial to clarify the clinical traits of perosphereirone in the treatment of schizophrenia.
A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia.
- Psychology, MedicineThe American journal of psychiatry
- 2009
The findings suggest that some second-generation antipsychotics may be somewhat more efficacious than others, but the limitations of meta-analysis must be considered in tailoring drug treatment to the individual patient.
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
- Psychology, MedicineMolecular Psychiatry
- 2005
A brief review and critique of the current therapeutic armamentarium for treating schizophrenia and drug development strategies and theories of mechanisms of action of antipsychotic drugs is provided, and focuses on novel targets for therapeutic agents for future drug development.
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
- Medicine, PsychologyThe Lancet
- 2009
Extrapyramidal symptom profiles in Japanese patients with schizophrenia treated with olanzapine or haloperidol
- Psychology, MedicineSchizophrenia Research
- 2002
Effects of changing from typical to atypical antipsychotic drugs on subjective sleep quality in patients with schizophrenia in a Japanese population.
- Psychology, MedicineThe Journal of clinical psychiatry
- 2004
It is demonstrated that atypical antipsychotic drugs improved subjective quality of sleep in patients with schizophrenia compared with conventional antipsychotics, suggesting that the marked potency of serotonin-2 receptor blockade in atypicals antippsychotic drugs may be involved in the mechanism of this improvement.
Current topics in neuroleptic-induced extrapyramidal symptoms in Japan.
- Psychology, MedicineThe Keio journal of medicine
- 1996
Current topics in neuroleptic-induced extrapyramidal symptoms in Japan are reviewed, focusing especially on the clinical features of akathisia and dystonia, and the Drug-Induced Extra-Pyramidal Symptoms Scale, which has recently been established.
Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.
- Medicine, PsychologyJAMA
- 2009
Weight gain and changes in lipid and metabolic parameters in patients without prior antipsychotic medication exposure are studied and mean levels increased significantly for total cholesterol, triglycerides, and non-high-density lipoprotein cholesterol.